Obstetric hemorrhage risk assessment tool predicts composite maternal morbidity

Abstract Obstetric hemorrhage is one of the leading preventable causes of maternal mortality in the United States. Although hemorrhage risk-prediction models exist, there remains a gap in literature describing if these risk-prediction tools can identify composite maternal morbidity. We investigate h...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Emer L. Colalillo, Andrew D. Sparks, Jaclyn M. Phillips, Chinelo L. Onyilofor, Homa K. Ahmadzia
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/ba60975536f744a687e4c7987c2fe597
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ba60975536f744a687e4c7987c2fe597
record_format dspace
spelling oai:doaj.org-article:ba60975536f744a687e4c7987c2fe5972021-12-02T16:26:23ZObstetric hemorrhage risk assessment tool predicts composite maternal morbidity10.1038/s41598-021-93413-32045-2322https://doaj.org/article/ba60975536f744a687e4c7987c2fe5972021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-93413-3https://doaj.org/toc/2045-2322Abstract Obstetric hemorrhage is one of the leading preventable causes of maternal mortality in the United States. Although hemorrhage risk-prediction models exist, there remains a gap in literature describing if these risk-prediction tools can identify composite maternal morbidity. We investigate how well an established obstetric hemorrhage risk-assessment tool predicts composite hemorrhage-associated morbidity. We conducted a retrospective cohort analysis of a multicenter database including women admitted to Labor and Delivery from 2016 to 2018, at centers implementing the Association of Women’s Health, Obstetric, and Neonatal Nurses risk assessment tool on admission. A composite morbidity score incorporated factors including obstetric hemorrhage (estimated blood loss ≥ 1000 mL), blood transfusion, or ICU admission. Out of 56,903 women, 14,803 (26%) were categorized as low-risk, 26,163 (46%) as medium-risk and 15,937 (28%) as high-risk for obstetric hemorrhage. Composite morbidity occurred at a rate of 2.2%, 8.0% and 11.9% within these groups, respectively. Medium- and high-risk groups had an increased combined risk of composite morbidity (diagnostic OR 4.58; 4.09–5.13) compared to the low-risk group. This established hemorrhage risk-assessment tool predicts clinically-relevant composite morbidity. Future randomized trials in obstetric hemorrhage can incorporate these tools for screening patients at highest risk for composite morbidity.Emer L. ColalilloAndrew D. SparksJaclyn M. PhillipsChinelo L. OnyiloforHoma K. AhmadziaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Emer L. Colalillo
Andrew D. Sparks
Jaclyn M. Phillips
Chinelo L. Onyilofor
Homa K. Ahmadzia
Obstetric hemorrhage risk assessment tool predicts composite maternal morbidity
description Abstract Obstetric hemorrhage is one of the leading preventable causes of maternal mortality in the United States. Although hemorrhage risk-prediction models exist, there remains a gap in literature describing if these risk-prediction tools can identify composite maternal morbidity. We investigate how well an established obstetric hemorrhage risk-assessment tool predicts composite hemorrhage-associated morbidity. We conducted a retrospective cohort analysis of a multicenter database including women admitted to Labor and Delivery from 2016 to 2018, at centers implementing the Association of Women’s Health, Obstetric, and Neonatal Nurses risk assessment tool on admission. A composite morbidity score incorporated factors including obstetric hemorrhage (estimated blood loss ≥ 1000 mL), blood transfusion, or ICU admission. Out of 56,903 women, 14,803 (26%) were categorized as low-risk, 26,163 (46%) as medium-risk and 15,937 (28%) as high-risk for obstetric hemorrhage. Composite morbidity occurred at a rate of 2.2%, 8.0% and 11.9% within these groups, respectively. Medium- and high-risk groups had an increased combined risk of composite morbidity (diagnostic OR 4.58; 4.09–5.13) compared to the low-risk group. This established hemorrhage risk-assessment tool predicts clinically-relevant composite morbidity. Future randomized trials in obstetric hemorrhage can incorporate these tools for screening patients at highest risk for composite morbidity.
format article
author Emer L. Colalillo
Andrew D. Sparks
Jaclyn M. Phillips
Chinelo L. Onyilofor
Homa K. Ahmadzia
author_facet Emer L. Colalillo
Andrew D. Sparks
Jaclyn M. Phillips
Chinelo L. Onyilofor
Homa K. Ahmadzia
author_sort Emer L. Colalillo
title Obstetric hemorrhage risk assessment tool predicts composite maternal morbidity
title_short Obstetric hemorrhage risk assessment tool predicts composite maternal morbidity
title_full Obstetric hemorrhage risk assessment tool predicts composite maternal morbidity
title_fullStr Obstetric hemorrhage risk assessment tool predicts composite maternal morbidity
title_full_unstemmed Obstetric hemorrhage risk assessment tool predicts composite maternal morbidity
title_sort obstetric hemorrhage risk assessment tool predicts composite maternal morbidity
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/ba60975536f744a687e4c7987c2fe597
work_keys_str_mv AT emerlcolalillo obstetrichemorrhageriskassessmenttoolpredictscompositematernalmorbidity
AT andrewdsparks obstetrichemorrhageriskassessmenttoolpredictscompositematernalmorbidity
AT jaclynmphillips obstetrichemorrhageriskassessmenttoolpredictscompositematernalmorbidity
AT chinelolonyilofor obstetrichemorrhageriskassessmenttoolpredictscompositematernalmorbidity
AT homakahmadzia obstetrichemorrhageriskassessmenttoolpredictscompositematernalmorbidity
_version_ 1718384077130694656